About our special guest

Dr. Kubick is CEO of the company B4 PharmaTech GmbH, a startup company on the campus of the “Freie Universität Berlin”, focused on the production of bioorthogonal systems for protein labeling. Prior to that, he was the international affairs officer and head of the department “Cell-free and Cell-based Bioproduction” at the Fraunhofer IZI-BB in Potsdam-Golm. He gained his PhD in Molecular Biology and Physiology from the University of Stuttgart-Hohenheim, Germany. During his postdoctoral research in the Institute of Pharmacology at the FU Berlin (Prof. Günter Schultz), he was involved in the characterization of cellular functions of G protein-mediated signal transduction processes. In 2000 he moved to RiNA GmbH, Berlin, to work as a senior scientist on the development and commercialization of novel solutions in the field of cell-free protein synthesis and labeling. In collaboration with Qiagen and Roche he developed a novel eukaryotic in vitro translation system. Since 2010 he has led a large group at the Fraunhofer IBMT and became head of the department “Cell-free Bioproduction”. His laboratory exploits cell-free protein synthesis as a versatile tool for functional genomics, membrane proteins and glycoproteins, chip-based protein synthesis and translational regulation. He is also a lecturer at the FU Berlin and the University of Potsdam. He is an affiliate of the TU Berlin and Lecturer at the University of Applied Sciences, Berlin, Germany. In addition, Dr. Kubick is a member of the Faculty of Health Sciences, joint Faculty of the Brandenburg TU Cottbus-Senftenberg, the Brandenburg Medical School Theodor Fontane and the University of Potsdam, Germany.